US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street Journal
TradingViewN
NVO
Novo-Nordisk A/S
74.01
-0.33-0.44%After Hours: 74.00 -0.01 -0.01%19:58 06/18 EDT
OPEN/PREV CLOSE74.56/74.34
TODAY RANGE73.70-74.82
VOL5.46M
MARKET CAP248.97B
52 WEEK RANGE57.00-145.16
AVG VOL (3M)10.07M
% TURNOVER0.16%
TURNOVER--
P/E (TTM)21.74
% RANGE1.50%
EPS(TTM)3.405
P/E(FORWARD)21.00
P/B16.49
BVPS4.488
DIVIDEND1.660
P/S8.15
BETA--
DIV YIELD2.24%
FREE FLOAT MKT CAP248.96B
SHARES OUTSTANDING3.36B
NEXT EARNINGS--
FREE FLOAT3.36B
LOT SIZE1
EX-DATE03/31/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·17h ago
The Fed's Faced With Macroeconomic Complexity
Benzinga·17h ago
How Do Investors Really Feel About Novo Nordisk?
Seeking Alpha·19h ago
Skye confirms phase 2 data on nimacimab for obesity expected later this year
Seeking Alpha·1d ago
U.S. judge rules FDA correctly removed Novo obesity drugs from its shortage list
NASDAQ·1d ago
NVO Factor-Based Stock Analysis - Warren Buffett
Benzinga·1d ago
Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study
Seeking Alpha·1d ago
Bariatric surgery better than GLP-1 drugs for weight loss : ASMBS study
The Motley Fool·1d ago
Novo Nordisk Just Improved Its Weight-Management Pipeline: Is the Stock a Buy?
Same Industry
Name/Symbol
Change%
Price